Therapy News and Research

RSS

Levetiracetam shows promise for epilepsy

People with newly diagnosed epilepsy experienced few, if any, seizures while taking the drug levetiracetam as a single therapy, giving hope to epilepsy patients who don't respond to or can't tolerate existing treatments, according to a study published in the February 6, 2007 issue of Neurology, the scientific journal of the American Academy of Neurology.

5 Feb 2007

Severe form of "enlarged prostate" discovered

Millions of middle-aged and older men experience the symptoms of an enlarged prostate multiple times during the day and night. What they may not know is that the disease known as BPH (benign prostatic hyperplasia), marked by urgency and frequent urination, is not one but at least a pair of disorders, and that one of the pair - tied to a newly identified gene - has far more serious implications.

5 Feb 2007

Cancer Research Technology grants Waypharm option to novel platinum agents

Cancer Research Technology Limited (CRT), the cancer-focused development and commercialisation company, today announce that Waypharm S.A.S (Waypharm) has secured rights to evaluate Thioplatin a novel hypoxia-responsive platinum-based cancer therapy, from CRT.

5 Feb 2007

New therapy teaches pain coping for those suffering from common jaw disorder

A new supplemental therapy that teaches pain coping and biofeedback skills can reduce pain, the potential for chronic pain and health-care costs for millions of Americans suffering from a common jaw disorder, UT Southwestern Medical Center researchers have found.

5 Feb 2007

Alphanate approved to treat Von Willebrand disease

The U.S. Food and Drug Administration (FDA) has announced the approval of Antihemophilic Factor/von Willebrand Factor Complex (Human), Alphanate.

4 Feb 2007

Some tips for SAD sufferers

Experts say the months after Christmas when winter really sets in can be the most difficult for sufferers with Seasonal Affective Disorder (SAD).

4 Feb 2007

Researchers identify human pancreatic cancer stem cells

Researchers at the University of Michigan Medical Center have, for the first time, identified human pancreatic cancer stem cells. Their work indicates that these cells are likely responsible for the aggressive tumor growth, progression, and metastasis that define this deadly cancer.

1 Feb 2007

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

1 Feb 2007

Study finds flaws in cancer trials

Cancer research and drug development are yielding more sophisticated candidate therapies, but investigators' methods to test them haven't kept pace, according to researchers at Memorial Sloan-Kettering Cancer Center.

1 Feb 2007

Seed implants critical for achieving a better prostate cancer outcome

More than ninety percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis, according to a study released in the February 1 issue of the International Journal for Radiation Oncology - Biology - Physics, the official journal of ASTRO.

31 Jan 2007

Effect of physical activities on knee osteoarthritis in older adults

Regular exercise is recommended for middle-aged and older people, but the effect of exercise on the development of osteoarthritis (OA) in older people is unclear, especially if they are overweight.

31 Jan 2007

Statins slow the progression of aortic valve stenosis

The trial provides the first prospective clinical evidence that aortic valves have an active biology that can be targeted with medical therapy and contradicts research published in 2005 in the New England Journal of Medicine, which concluded statins did not halt the progression of aortic stenosis.

30 Jan 2007

Psychological effects of heart surgery

Cases of congenital heart disease (CHD), in both adolescents and adults, have been on the rise for many years.

30 Jan 2007

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies.

30 Jan 2007

A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis

Marked by chronic inflammation of the joints and tissue, rheumatoid arthritis (RA) is a painful and potentially disabling autoimmune disease.

30 Jan 2007

Merck Serono launches growth hormone injection device

Merck Serono has announced the launch of a unique growth hormone injection device, easypod, for the once-daily administration of Saizen (somatropin), the company's recombinant growth hormone deficiency therapy. easypod is the first of its kind in this therapeutic area and was designed to improve patients' ease of daily use, reliability and convenience.

30 Jan 2007

Drug giant Wyeth loses another HRT trial to the tune of $1.5 million

Drug giant Wyeth has been ordered by a court in Philadelphia to pay $1 million in compensation to a woman who developed breast cancer after taking the hormone replacement therapy (HRT) Prempro.

30 Jan 2007

Stroke treatment helps victims recover brain function

A small but significant study in the U.S. has found that a treatment which was designed to clear blocked carotid arteries and prevent stroke has also improved brain function.

29 Jan 2007

New testing approach to predict outcome in patients with bladder cancer

A new testing approach has been shown to be effective in identifying patients at the highest risk of cancer relapse after surgery for bladder cancer, say researchers in the February issue of The Lancet Oncology.

29 Jan 2007

Time, therapy spur recovery from sudden sensorineural hearing loss

A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.

29 Jan 2007